PointState Capital’s Acceleron Pharma XLRN Stock Holding History

PointState Capital’s Portfolio XLRN Stock Details XLRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-6,000	Closed	-$1.03M	–	188
2021 Q3	$1.03M	Buy	+6,000	New	+$785K	0.02%	126
2015 Q2	–	Sell	-475,000	Closed	-$18.1M	–	184
2015 Q1	$18.1M	Buy	+475,000	New	+$18.9M	0.24%	68

PointState Capital's XLRN Position: Q4 2021 in Review

PointState Capital sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 6,000 shares — an estimated $1.03M sold.

PointState Capital first reported a position in XLRN in Q1 2015 and held it in 2 quarters. The position peaked at $18.1M in Q1 2015. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.

PointState Capital reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
PointState Capital sold 6,000 Acceleron Pharma shares in Q4 2021, an estimated $1.03M.
PointState Capital first reported a position in Acceleron Pharma in Q1 2015 and held it in 2 quarters.
PointState Capital's Acceleron Pharma position peaked at $18.1M in Q1 2015.
1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.

Based on PointState Capital's 13F filing for Q4 2021, filed 11 Feb 2022.